Markers of T cell senescence in humans

International Journal of Molecular Sciences

Volumn 18, Issue 8, 2017, Pages

  Xu, Weili ^a,b   Larbi, Anis ^a,b,c,d,e  

^a AGENCY FOR SCIENCE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF SHERBROOKE   (Canada)

^e FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

Author keywords

Human aging; Immune system; Immunosenescence; Markers; Phenotyping; Senescence; T cells

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD57 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; NATURAL KILLER CELL LECTIN LIKE RECEPTOR; PERFORIN; PROTEIN P16; PROTEIN P21; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR; ZINC FINGER PROTEIN;

AGING; CELL ASSAY; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; FLOW CYTOMETRY; HUMAN; IMMUNOSENESCENCE; MUCOSAL-ASSOCIATED INVARIANT T CELL; NATURAL KILLER T CELL; PERSISTENT INFECTION; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; CELL AGING; CYTOLOGY; IMMUNOLOGY; IMMUNOPHENOTYPING; PROCEDURES;

AGING; CELL DIFFERENTIATION; CELLULAR SENESCENCE; HUMANS; IMMUNOPHENOTYPING; IMMUNOSENESCENCE; T-LYMPHOCYTES;

EID: 85027342245     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18081742     Document Type: Review

References (106)

1. OECD. Elderly Population (Indicator). 2017. Available online: https://data.oecd.org/pop/elderly-population.htm (accessed on 5 May 2017).
2. World Population Ageing. Available online: http://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2015_Report.pdf (accessed on 5 May 2017).
3. The World Bank. Investing in Health: World Development Indicators; Oxford University Press: New York, NY, USA, 1993.
4. Wright, J.C.; Weinstein, M.C. Gains in life expectancy from medical interventions. N. Engl. J. Med. 1998, 339, 1943–1944.
5. Here’s the Visual Proof of Why Vaccines Do More Good than Harm. Available online: http://www.science mag.org/news/2017/04/heres-visual-proof-why-vaccines-do-more-good-harm (accessed on 15 June 2017).
6. Plassman, B.L.; Langa, K.M.; Fisher, G.G.; Heeringa,S.G.; Weir, D.R.; Ofstedal, M.B.; Burke, J.R.; Hurd, M.D.; Potter, G.G.; Rodgers, W.L.; et al. Prevalence of dementia in the United States: The aging, demographics, and memory study. Neuroepidemiology 2007, 29, 125–132.
7. Kamel, H.K. Sarcopenia and Aging. Nutr. Rev. 2003, 61, 157–167, doi:10.1301/nr.2003.may.157-167.
8. Machierira-Coelho, A. Cancer and aging. Exp. Gerontol. 1986, 23, 483–495.
9. Lesnefsky, E.J.; Moghaddas, S.; Tandler, B.; Kerner, J.; Hoppel, C.L. Mitochondrial dysfunction in cardiac Disease: Ischemia–reperfusion, aging, and heart failure. J. Mol. Cell. Cardiol. 2001, 33, 1065–1089.
10. Yazici, Y.; Paget, S.A. Elderly-onset rheumatoid arthritis. Rheum. Dis. Clin. N. Am. 2000, 26, 517–526.
11. Plotkin, S.A. Vaccines: Past, present and future. Nat. Med. 2005, 11, S5–S11.
12. Lang, P.-O.; Mendes, A.; Socquet, J.; Assir, N.; Govind, S.; Aspinall, R. Effectiveness of influenza vaccine in aging and older adults: Comprehensive analysis of the evidence. Clin. Interv. Aging 2012, 7, 55–64.
13. Lord, J.M. The effect of aging of the immune system on vaccination responses. Hum. Vaccines Immunother. 2013, 9, 1364–1367.
14. Aspinall, R.; Giudice, G.D.; Effros, R.B.; Loebenstein, B.G.; Sambhara, S. Challenges for vaccination in the elderly. Immun. Ageing 2007, 4, 9.
15. Larbi, A.; Fulop, T. From “truly naïve” to “exhausted senescent” T cells: When markers predict functionality. Cytom. Part A 2014, 85, 25–35.
16. Wingender, G.; Kronenberg, M. OMIP-030: Characterization of human T cell subsets via surface markers. Cytom. Part A 2015, 87, 1067–1069.
17. Delves, P.J.; Roitt, I.M. The immune system: First of two parts. N. Engl. J. Med. 2000, 37–49, doi:10.1056/NEJM200007063430107.
18. Kumar, H.; Kawai, T.; Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30, 16–34.
19. MacLeod, M.K.L.; Kappler, J.W.; Marrack, P. Memory CD4 T cells: Generation, reactivation and re-assignment. Immunology 2010, 130, 10–15.
20. Obar, J.J.; Lefrançois, L. Memory CD8+ T cell differentiation. Ann. N. Y. Acad. Sci. 2010, 1183, 251–266.
21. Zhu, J.; Paul, W.E. CD4 T cells: Fates, functions, and faults. Immunobiology 2009, 112, 1557–1569.
22. Zhang, N.; Bevan, M.J. CD8+ T cells: Foot soldiers of the immune system. Immunity 2011, 35, 161–168, doi:10.1016/j.immuni.2011.07.010.
23. Zhu, J.; Yamane, H.; Paul, W. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 2010, 28, 445–489.
24. Bousso, P. T-cell activation by dendritic cells in the lymph node: Lessons from the movies. Nat. Rev. Immunol. 2008, 8, 675–684.
25. Janeway, C.A., Jr.; Travers, P.; Walport, M.; et al. B-cell activation by armed helper T cells. In Immunobiology: The Immune System in Health and Disease, 5th ed.; Garland Science: New York, NY, USA, 2001. Available online: https://www.ncbi.nlm.nih.gov/books/NBK27142/(accessed on 10 June 2017).
26. Janeway, C.A., Jr.; Travers, P.; Walport, M.; Shlomchik, M.J. Macrophage activation by armed CD4 TH1 cells. In Immunobiology: The Immune System in Health and Disease, 5th ed.; Garland Science: New York, NY, USA, 2001. Available online: https://www.ncbi.nlm.nih.gov/books/NBK27153/(accessed on 11 June 2017).
27. Janeway, C.A., Jr.; Travers, P.; Walport, M.; Shlomchik, M.J. T cell-mediated cytotoxicity. In Immunobiology: The Immune System in Health and Disease, 5th ed.; Garland Science: New York, NY, USA, 2001. Available online: https://www.ncbi.nlm.nih.gov/books/NBK27101/(accessed on 12 June 2017).
28. Langhoff, E.; Steinman, R.M. Clonal expansion of human T lymphocytes initiated by dendritic cells. J. Exp. Med. 1989, 169, 315–320.
29. Effros, R.B.; Pawelec, G. Replicative senescence of T cells: Does the Hayflick limit lead to immune exhaustion? Immunol. Today 1997, 18, 450–454.
30. Effros, R.B. Replicative senescence in the immune system: Impact of the Hayflick limit on T-cell function in the elderly. Am. J. Hum. Genet. 1998, 62, 1003–1007.
31. Hodes, R.J.; Hathcock, K.S.; Weng, N. Telomeres in T and B cells. Nat. Rev. Immunol. 2002, 2, 699–706.
32. Shay, J.W.; Wright, W.E. Hayflick, his limit and cellular aging. Nat. Rev. Mol. Cell Biol. 2000, 1, 72–76.
33. Coppé, J.-P.; Desprez, P.-Y.; Krtolica, A.; Campisi, J. The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu. Rev. Pathol. Mech. Dis. 2010, 5, 99–118.
34. Mahnke, Y.D.; Brodie, T.M.; Sallusto, F.; Roederer, M.; Lugli, E. The who’s who of T-cell differentiation: Human memory T-cell subsets. Eur. J. Immunol. 2013, 43, 2797–2809.
35. King, C. New insights into the differentiation and function of T follicular helper cells. Nat. Rev. Immunol. 2009, 9, 757–766, doi:10.1038/nri2644.
36. Ahmed, R.; Bevan, M.J.; Reiner, S.L.; Fearon, D.T. The precursors of memory: Models and controversies. Nat. Rev. Immunol. 2009, 9, 662–668, doi:10.1038/nri2619.
37. Rosenblum, M.D.; Way, S.S.; Abbas, A.K. Regulatory T cell memory. Nat. Rev. Immunol. 2016, 16, 90–101, doi:10.1038/nri.2015.1.
38. Kaech, S.M.; Wherry, E.J.; Ahmed, R. Effector and memory T-cell differentiation: Implications for vaccine development. Nat. Rev. Immunol. 2002, 2, 251–262.
39. Förster, R.; Davalos-Misslitz, A.C.; Rot, A. CCR7 and its ligands: Balancing immunity and tolerance. Nat. Rev. Immunol. 2008, 8, 362–371.
40. Dolfi, D.V.; Katsikis, P.D. CD28 and CD27 costimulation of CD8+ T cells: A story of survival. Adv. Exp. Med. Biol. 2007, 590, 149–170.
41. Koch, S.; Larbi, A.; Derhovanessian, E.; Ozcelik, D.; Naumova, E.; Pawelec, G. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun. Ageing 2008, 5, 6.
42. Stubbe, M.; Vanderheyde, N.; Goldman, M.; Marchant, A. Antigen-specific central memory CD4+ T lymphocytes produce multiple cytokines and proliferate in vivo in humans. J. Immunol. 2006, 177, 8185– 8190.
43. Henson, S.M.; Akbar, A.N. KLRG-1—More than a marker for T cell senescence. Age (Omaha) 2009, 31, 285–291.
44. Henson, S.; Franzese, O.; Macaulay, R.; Libri, V.; Azevedo, R.I.; Kiani-Alikhan, S.; Plunkett, F.J.; Masters, J.E.; Jackson, S.; Griffiths, S.J.; et al. KLRG-1 signalling induced proliferative dysfunction and defective Aktser473 phosphorylation in highly differentiated human CD8+ T cells. Blood 2009, 113, 1–3.
45. Brenchley, J.M.; Karandikar, N.J.; Betts, M.R.; Ambrozak, D.R.; Hill, B.J.; Crotty, L.E.; Casazza, J.P.; Kuruppu, J.; Migueles, S.A.; Connors, M.; et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8. Blood 2003, 101, 2711–2720.
46. Palmer, B.E.; Blyveis, N.; Fontenot, A.P.; Wilson, C.C. Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J. Immunol. 2005, 175, 8415–8423.
47. Chou, J.P.; Effros, R.B. T cell replicative senescence in human aging. Curr. Pharm. Des. 2013, 19, 1680–1698.
48. Liu, Y.; Sanoff, H.K.; Cho, H.; Burd, C.E.; Torrice, C.; Ibrahim, J.G.; Thomas, N.E.; Sharpless, N.E. Expression of p16INK4a in peripheral blood T-cells is a biomarker of human aging. Aging Cell 2009, 8, 439–448, doi:10.1111/j.1474-9726.2009.00489.x.
49. Porath, I.B.; Weinberg, R.A. When cells get stressed: An integrative view of cellular senescence. J. Clin. Investig. 2004, 113, 8–13, doi:10.1172/JCI200420663.
50. Shawi, M.; Autexier, C. Telomerase, senescence and ageing. Mech. Ageing Dev. 2008, 129, 3–10.
51. Qian, Y.; Chen, X. Tumor suppression by p53: Making cells senescent. Histol. Histopathol. 2010, 25, 515– 526.
52. Munoz-Espin, D.; Serrano, M. Cellular senescence: From physiology to pathology. Nat. Rev. Mol. Cell Biol. 2014, 15, 482–496.
53. Bernadotte, A.; Mikhelson, V.M.; Spivak, I.M. Markers of cellular senescence. Telomere shortening as a marker of cellular senescence. Aging (Albany NY) 2016, 8, 3–11.
54. Plunkett, F.J.; Franzese, O.; Finney, H.M.; Fletcher, J.M.; Belaramini, L.L.; Salmon, M.; Dokal, I.; Webster, D.; Lawson, A.D.G.; Akbar, A.N. The loss of telomerase activity in highly differentiated CD8+CD28−CD27− T cells is associated with decreased Akt (Ser473) phosphorylation. J. Immunol. 2007, 178, 7710–7719.
55. Lanna, A.; Henson, S.M.; Escors, D.; Akbar, A.N. The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat. Immunol. 2014, 15, 965–972.
56. Crespo, J.; Sun, H.; Welling, T.H.; Tian, Z.; Zou, W. T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr. Opin. Immunol. 2013, 25, 214–221.
57. Wherry, E.J. T cell exhaustion. Nat. Immunol. 2011, 12, 492–499.
58. Shi, F.; Shi, M.; Zeng, Z.; Qi, R.Z.; Liu, Z.W.; Zhang, J.Y.; Yang, Y.P.; Tien, P.; Wang, F.S. PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Int. J. Cancer 2011, 128, 887–896.
59. Barber, D.L.; Wherry, E.J.; Masopust, D.; Zhu, B.; Allison, J.P.; Sharpe, A.H.; Freeman, G.J.; Ahmed, R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439, 682–687.
60. Zarour, H.M. Reversing T-cell dysfunction and exhaustion in cancer. Clin. Cancer Res. 2016, 22, 1856–1864.
61. Weber, J. Anti CTLA-4 antibody ipilimumab: Case studies of clinical response and immune-related adverse events. Oncologist 2007, 12, 864–872.
62. Weber, J.S.; Angelo, S.P.D.; Minor, D.; Hodi, F.S.; Gutzmer, R.; Neyns, B.; Hoeller, C.; Khushalani, N.; Miller, W.H., Jr.; Lao, C.D.; et al. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): A randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 2015, 16, 375–384.
63. Rizvi, N.A.; Maziaeres, J.; Planchard, D.; Stinchcombe, T.E.; Dy, G.K.; Anotonia, S.J.; Horn, L.; Lena, H.; Minenza, E.; Menncier, B.; et al. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): A phase 2, single-arm trial. Lancet Oncol. 2015, 16, 257–265.
64. Maio, M.; Grob, J.J.; Aamdal, S.; Bondarenko, I.; Robert, C.; Thomas, L.; Garbe, C.; Chiarion-Sileni, V.; Testori, A.; Chen, T.T.; et al. Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial. J. Clin. Oncol. 2015, 33, 1191– 1196.
65. Sharma, P.; Allison, J.P. The future of immune checkpoint therapy. Science 2015, 348, 56–61, doi:10.1126/science.aaa8172.
66. Sansoni, P.; Vescovini, R.; Fagnoni, F.F.; Akbar, A.N.; Aren, R.; Chiu, Y.L.; Cicin-Sain, L.; Dechanet-Mervile, J.; Derhovanessian, E.; Ferrado-Martinez, S.; et al. New advances in CMV and immunosenescence. Exp. Gerontol. 2014, 55, 54–62.
67. Klenerman, P.; Oxenius, A. T cell responses to cytomegalovirus. Nat. Rev. Immunol. 2016, 16, 367–377.
68. Deeks, S.G. HIV infection, inflammation, immunosenescence, and aging. Annu. Rev. Med. 2011, 62, 141– 155, doi:10.1146/annurev-med-042909-093756.
69. Fülöp, T.; Larbi, A.; Pawelec, G. Human T cell aging and the impact of persistent viral infections. Front. Immunol. 2013, 4, 1–9.
70. Palmer, D.B. The effect of age on thymic function. Front. Immunol. 2013, 4, 1–6.
71. Aspinall, R.; Pitts, D.; Lapenna, A.; Mitchell, W. Immunity in the elderly: The role of the thymus. J. Comp. Pathol. 2010, 142 (Suppl. 1), S111–S115, doi:10.1016/j.jcpa.2009.10.022.
72. Pang, W.W.; Price, E.A.; Sahoo, D.; Beerman, I.; Maloney, W.J.; Rossi, D.J.; Schrier, S.L.; Weissman, I.L. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc. Natl. Acad. Sci. USA 2011, 108, 20012–20017, doi:10.1073/pnas.1116110108.
73. Linton, P.J.; Dorshkind, K. Age-related changes in lymphocyte development and function. Nat. Immunol. 2004, 5, 133–139.
74. Taub, D.D.; Longo, D.L. Insights into thymic aging and regeneration. Immunol. Rev. 2005, 205, 72–93.
75. Bredenkamp, N.; Nowell, C.S.; Blackburn, C.C. Regeneration of the aged thymus by a single transcription factor. Development 2014, 141, 1627–1637.
76. Franceschi, C.; Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2014, 69, S4–S9.
77. Khansari, N.; Shakiba, Y.; Mahmoudi, M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat. Inflamm. Allergy Drug Discov. 2009, 3, 73–80.
78. Nikolich-Zugich, J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat. Rev. Immunol. 2008, 8, 512–522.
79. Goronzy, J.J.; Fang, F.; Cavanagh, M.M.; Qi, Q.; Weyand, C.M. Naive T cell maintenance and function in human aging. J. Immunol. 2015, 194, 4073–4080.
80. Demaria, M.; Ohtani, N.; Youssef, S.A.; Rodier, F.; Toussaint, W.; Mitchell, J.R.; Laberge, R.M.; Vijg, J.; Steeg, H.V.; Dolle, M.E.T.; et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 2014, 31, 722–733.
81. Jun, J.-I.; Lau, L.F. Cellular senescence controls fibrosis in wound healing. Aging (Albany NY) 2010, 2, 627– 631.
82. Lanier, L.L. Shades of grey—The blurring view of innate and adaptive immunity. Nat. Rev. Immunol. 2013, 13, 73–74.
83. Wencker, M.; Turchinovich, G.; Barros, R.D.M.; Deban, L.; Jandke, A.; Cope, A.; Hayday, A.C. Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness. Nat. Immunol. 2014, 15, 80–87.
84. Dadi, S.; Chhangawala, S.; Whitlock, B.M.; Huse, M.; Leslie, C.S.; Li, M.O. Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells. Cell 2016, 164, 365–377.
85. Novak, J.; Dobrovolny, J.; Novakova, L.; Kozak, T. The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of reproductive age. Scand. J. Immunol. 2014, 80, 271–275.
86. Vasudev, A.; Tan, C.T.Y.; Ayyadhury, S.; Puan, K.J.; Andiappan, A.K.; Nyunt, M.S.Z.; Shadan, N.B.; Mustafa, S.; Low, I.; Rotzschke, O.; et al. γ/δ T cell subsets in human aging using the classical α/β T cell model. J. Leukoc. Biol. 2014, 96, 647–655.
87. Tan, C.; Wistuba-Hamprecht, K.; Xu, W.; Nyunt, M.S.Z.; Vasudev, A.; Lee, B.T.K.; Pawalec, G.; Puan, K.J; Rotzschke, O.; Ng, T.P.; et al. Vδ2+ and α/ß T cells show divergent trajectories during human aging. Oncotarget 2016, 7, 44906–44918.
88. (+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc. Natl. Acad. Sci. USA 2016, 113, 14378–14383.
89. Eberl, M.; Engel, R.; Aberle, S.; Fisch, P.; Jomaa, H. Human Vγ9/Vδ2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1). J. Leukoc. Biol. 2005, 77, 16–19.
90. Wistuba-Hamprecht, K.; Frasca, D.; Blomberg, B.; Pawelec, G.; Derhovanessian, E. Age-associated alterations in gammadelta T-cells are present predominantly in individuals infected with cytomegalovirus. Immun. Ageing 2013, 10, 26.
91. Davey, M.S.; Willcox, C.R.; Joyce, S.P.; Ladell, K.; Kasatskaya, S.A.; McLaren, J.E.; Hunter, S.; Salin, M.; Mohammed, F.; Price, D.A.; et al. Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance. Nat. Commun. 2017, 8, 14760.
92. Dominguez, C.X.; Amezquita, R.A.; Guan, T.; Marshall, H.D.; Joshi, N.S.; Kleinstein, S.H.; Kaech, S.M. The transcription factors Zeb2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection. J. Exp. Med. 2015, 212, 2041–2056.
93. Yu, D.M.; Jung, S.H.; An, H.T.; Lee, S.; Hong, J.; Park, J.S.; Lee, H.; Bahn, M.S.; Lee, H.C.; Han, N.K.; et al. Caveolin-1 deficiency induces premature senescence with mitochondrial dysfunction. Aging Cell 2017, doi:10.1111/acel.12606.
94. Yu, D.; Du, Z.; Pian, L.; Li, T.; Wen, X.; Li, W.; Kim, S.J.; Xiao, J.; Cohen, P.; Cui, J.; et al. Mitochondrial DNA hypomethylation is a biomarker associated with induced senescence in human fetal heart mesenchymal stem Cells. Stem Cells Int. 2017, 2017, 1764549, doi:10.1155/2017/1764549.
95. Ademowo, O.S.; Dias, H.K.I.; Burton, D.G.A.; Griffiths, H.R. Lipid (per) oxidation in mitochondria: An emerging target in the ageing process? Biogerontology 2017, doi:10.1007/s10522-017-9710-z.
96. Mendelsohn, A.R.; Larrick, J.A. NAD+/PARP1/SIRT1 axis in aging. Rejuvenation Res. 2017, doi:10.1089/rej.2017.1980.
97. Chatuvedi, P.; Tyagi, S.C. NAD+: A big player in cardiac and skeletal muscle remodeling and aging. J. Cell Physiol. 2017, doi:10.1002/jcp.26014.
98. Verdin, E. NAD⁺ in aging, metabolism, and neurodegeneration. Science 2015, 350, 1208–1213, doi:10.1126/science.aac4854.
99. Panda, A.C.; Abdelmohsen, K.; Gorospe, M. SASP regulation by noncoding RNA. Mech. Ageing Dev. 2017, doi:10.1016/j.mad.2017.05.004.
100. Xing, W.; Gao, W.; Mao, G.; Zhang, J.; Lv, X.; Wang, G.; Yan, J. Long non-coding RNAs in aging organs and tissues. Clin. Exp. Pharmacol. Physiol. 2017, doi:10.1111/1440-1681.12795.
101. Zhu, Y.; Xiong, K.; Shi, J.; Cui, Q.; Xue, L. A potential role of microRNAs in protein accumulation in cellular senescence analyzed by bioinformatics. PLoS ONE 2017, 12, e0179034, doi:10.1371/journal.pone.0179034.
102. Bu, H.; Wedel, S.; Cavinato, M.; Jansen-Dürr, P. MicroRNA regulation of oxidative stress-induced cellular senescence. Oxid. Med. Cell. Longev. 2017, 2017, 2398696, doi:10.1155/2017/2398696.
103. Moskowitz, D.M.; Zhang, D.W.; Hu, B.; Le Saux, S.; Yanes, R.E.; Ye, Z.; Buenrostro, J.D.; Weyand, C.M.; Greenleaf, W.J.; Goronzy, J.J. Epigenomics of human CD8 T cell differentiation and aging. Sci. Immunol. 2017, 2, eaag0192, doi:10.1126/sciimmunol.aag0192.
104. Durek, P.; Nordstrom, K.; Gasparoni, G.; Salhab, A.; Kressler, K.C.; de Almeida, M.; Bassler, K.; Ulas, T.; Schmidt, F.; Xiong, J.; et al. Epigenomic profiling of human CD4+ T cells supports a linear differentiation model and highlights molecular regulators of memory development. Immunity 2016, 45, 1148–1161.
105. Schulyer, R.P.; Merkel, A.; Raineri, E.; Altucci, L.; Vellenga, E.; Martens, J.H.; Pourfarzad, F.; Kuijpers, T.W.; Burden, F.; Farrow, S.; et al. Distinct trends of DNA methylation patterning in the innate and adaptive immune systems. Cell Rep. 2016, 17, 2101–2111.
106. Yang, H.; Wang, H.; Ren, J.; Chen, Q.; Chen, Z.J. cGAS is essential for cellular senescence. Proc. Natl. Acad. Sci. USA 2017, 114, E4612–E4620, doi:10.1073/pnas.1705499114.